Review Article
Tumor Antigen-Dependent and Tumor Antigen-Independent Activation of Antitumor Activity in T Cells by a Bispecific Antibody-Modified Tumor Vaccine
Figure 3
Activation of naive T cells towards tumor cells by the NDV-based tumor vaccine combined with bsAbs in different combinations.